Follicular Homing T Helper (Th) Cells and the Th1/Th2 Paradigm by Mackay, Charles R.
 
J. Exp. Med. 
 
Ó
 
 The Rockefeller University Press • 0022-1007/2000/12/F31/04 $5.00
Volume 192, Number 11, December 4, 2000 F31–F34
http://www.jem.org/cgi/content/full/192/11/F31
 
Commentary
 
F31
 
Follicular Homing T Helper (Th) Cells and the 
Th1/Th2 Paradigm
 
By Charles R. Mackay
 
From the Garvan Institute of Medical Research, New South Wales 2010, Australia
 
The Th1/Th2 paradigm is a cornerstone for our under-
standing of T cell responses (1). It conveniently subdivides
T cell immune responses into those specialized for defense
against intracellular pathogens including viruses and some
bacteria (Th1), and a second for defense against large extra-
cellular pathogens such as helminths. Th1 responses depend
 
on IL-12 and IFN-
 
g
 
 to mediate a range of biological effects
designed for antiviral immunity. In contrast, Th2 responses
employ the cytokines IL-5, IL-4, and IL-13, which pro-
mote the mobilization of eosinophils and cause other in-
flammatory processes designed to expel large parasites. The
Th1/Th2 paradigm also has particular relevance for certain
inflammatory diseases, as asthma is essentially a Th2 re-
sponse gone awry, and many autoimmune diseases depend
on a Th1 response to autoantigens. However, this neat
scheme had one troubling aspect: where do helper cells for
antibody production fit in? T cell help for antibody pro-
duction has long been considered a Th2 property (2, 3), al-
though certain Ig class switching relies on IFN-
 
g
 
.
As acceptance of the Th1/Th2 paradigm increased
among immunologists, so too has the effort to identify
Th1- or Th2-associated genes or molecules. Numerous
transcription factors/signal transducers such as T-bet, signal
transducer and activator of transcription (Stat)-6, GATA-3,
and Stat-4 were identified that determined Th1 or Th2 dif-
ferentiation and function (4–6). In mice deficient in Stat-6,
a Th2 transcription factor, IL-4 signaling is abolished and
Th2 responses are absent. Nevertheless, these mice are still
capable of mounting T cell–dependent antibody responses
(although not IgE, an isotype for mast cell activation). The
discovery of the various Th1- and Th2-related transcrip-
tion factors cemented the validity of the Th1/Th2 para-
digm, but what remained unclear was the precise role of
Th1 cytokine–producing, or Th2 cytokine–producing cells
in different immune responses.
Cell surface molecules that reliably mark Th1 or Th2
cells were also sought, and to date the chemokine receptors
are probably the most convenient (although by no means
ideal) markers of functional subsets. Th1 cells preferentially
express CC chemokine receptor (CCR)5 and CXC
chemokine receptor (CXCR)3, and migrate in response to
a select set of chemokines induced by cytokines such as
IFN-
 
g
 
 or IL-1, whereas Th2 cells preferentially express
CCR3 and CCR4 and migrate to chemokines induced by
IL-4 or IL-13 (7–12). The regulated expression of
chemokine receptors by effector T cells relates to the sim-
ple concept that migration or positioning of a cell is inti-
mately connected to that cell’s function (11). In this issue,
two groups have provided one of the best examples of this
concept, by identifying CXCR5 as a chemokine receptor
responsible for the follicular homing of a unique subset of
T helper cells for antibody production (13, 14). This subset
of T cells could be distinguished from Th1 or Th2 cells,
and would thus represent a third class of effector-type T
cell.
 
T and B Cell Positioning in Lymphoid Tissue.
 
T and B
cells continuously recirculate from blood to lymphoid tis-
sue, gaining entry through their expression of L-selectin
and the chemokine receptor CCR7. B cells localize in the
B cell follicles, whereas T cells colocalize with dendritic
cells in the T cell areas. This segregation is necessary be-
cause it is important for unprimed T cells to first receive
signals from professional APCs (dendritic cells) and not
from B cells. A specific sequence of cellular movements
then accompanies successful T cell priming (15). Activated
T cells migrate to the B cell follicles and position them-
selves at the edge of the follicle, where they meet antigen-
primed B cells that have also specifically migrated out-
 
wards. The two cell types then physically interact to
accomplish CD40-CD154–dependent B cell activation.
Thereafter, antigen-primed T cells become distributed
throughout the entire follicle, presumably to egg on the
germinal center reaction.
This lymphocyte positioning is tightly controlled by
chemokine–chemokine receptor interactions (16). The
constant traffic of resting T cells through lymphoid tissue is
controlled by “lymphoid” chemokines. T cell activation in
the T cell areas results in a loss of responsiveness to lym-
phoid chemokines and gain of responsiveness to the
chemokine CXCL13 (also called B cell–attracting chemo-
kine [BCA]-1/B lymphocyte chemoattractant [BLC]; ref-
erence 17). CXCL13 binds to the chemokine receptor
CXCR5, and mice deficient in CXCR5 or CXCL13 have
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disorganized lymphoid architecture and
 
 
 
impaired antibody
responses (18, 19). The directed migration of T cells into
the B cell follicles (15), the gain of CXCR5 upon T cell
activation, and the expression of CXCL13 by stromal cells
in the follicles (17) suggested that CXCR5 marked follicle
homing T cells.
 
Follicular B Helper T Cells.
 
CXCR5 was originally con-
sidered a B cell chemokine receptor. An antibody to
CXCR5 was produced that stained all B cells, and also an
interesting subset of CD45RO
 
1
 
 (memory) T cells in blood
and lymphoid tissue (20). CXCR5
 
1
 
 T cells were found to
be almost all CD4
 
1
 
, suggesting a role in T helper cell mi-
gration. A more comprehensive examination of these T
cells (13, 14) revealed an important distinction between
blood and tonsils. Inflamed tonsils (but not blood) con-
tained CXCR5
 
1
 
 T cells that were activated and distinct
from circulating T cells. For instance, the tonsilar
CXCR5
 
1
 
 T cells expressed CD69 and inducible costimu-
lator (ICOS), and were generally L-selectin–negative. Ex-
pression of ICOS is particularly noteworthy, as this mole-
cule is a CD28-like family member that facilitates effector
T cell responses, rather than primary T cell activation.
ICOS probably participates in all effector T cell responses,
particularly T cell help for antibody production (21–23);
however, Th1 responses may rely less on ICOS, as strongly
polarized Th1 cells downregulate ICOS (22). ICOS binds
to a B7 relative termed B7RP-1, which is expressed abun-
 
dantly on B cells (21). The other notable feature of
CXCR5
 
1
 
 T cells is that they do not produce the typical
Th1 or Th2 cytokines, although a proportion do produce
IL-2. Thus, CXCR5
 
1
 
 lymphoid T cells have all the hall-
marks of effector function, but not Th1 or Th2 function or
phenotype.
The distinguishing feature of CXCR5
 
1
 
 T cells from
lymphoid tissue is that they are capable of providing help
for antibody responses (13, 14). Whether these T cells pro-
duce a B cell helper cytokine is not yet known, although it
is conceivable that they deliver help to B cells purely
through cell–cell contact and activation through ICOS and
other surface molecules. The involvement of CXCR5
 
1
 
 T
cells in B cell responses was also suggested by their localiza-
tion in the mantle and light zone of germinal centers. In-
deed all T cells that localize in B cell follicles are CXCR5
 
1
 
.
The distinction of a new subset of effector T cells with
classic T helper function for Ig production led the two
groups to label these cells “follicular B helper T cells”
(T
 
FH
 
). In contrast to tonsilar T
 
FH
 
 cells, the CXCR5
 
1
 
 T
cells in blood do not display effector function and may rep-
resent a circulating T
 
FH
 
-type memory cell. These blood
CXCR5
 
1
 
 T cells express CCR7, a chemokine receptor for
naive and memory lymphocyte recirculation that is often
absent from activated effector T cells (24). A cartoon de-
picting the phenotype and positioning properties of T
 
FH
 
cells in lymphoid tissue is presented in Fig. 1.
Figure 1. Development and positioning
of subsets of effector T cells in lymphoid tis-
sue. Naive T cells and dendritic cells colo-
calize in the T cell zones, through actions of
chemokines such as CCL19 (macrophage
inflammatory protein [MIP]-3b). Naive T
cell activation is dependent on CD28–B7-1
or –B7-2 interactions. For CD41 cells, at
least three effector subsets may arise: Th1
cells, Th2 cells, or TFH cells. TFH cells can
be distinguished by their expression of
CXCR5 and their ability to position within
B cell follicles, whereas Th1 and Th2 ex-
press other chemokine receptors. TFH differ
from Th1 or Th2 cells by their lack of cy-
tokine production. Similar to Th2 cells,
they express high levels of ICOS, a CD28-
like molecule that binds B7RP-1 expressed
on B cells. The issue of whether Th1 and
Th2 cells localize within B cell follicles is
unresolved, although the cytokines they
produce certainly influence B cell develop-
ment. IL-4 stimulates B cells and induces
IgE isotype switching, whereas IFN-g in-
duces IgG isotypes for antiviral defence.
The exact relationship of TFH to Th1 and
Th2 cells is undetermined, and it is possible
that TFH cells derive from either cell type.
CXCR51 T cells in blood (descendents
from TFH?) have a phenotype consistent
with memory rather than effector function.
Phenotypes listed are generalizations. 
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Relationship of T
 
FH
 
 to Th1 and Th2 Cells.
 
The discov-
ery of a non-Th1, non-Th2 effector T cell for B cell help
poses an interesting question: what to make of all the previ-
ous data implicating Th2 cells as helper cells for antibody
responses? A plausible explanation is that T
 
FH
 
 cells are de-
rived from Th2 or Th1 cells. There is no doubt about the
profound effects that IL-4, a Th2 cytokine, has on B cell
responses, including upregulation of costimulatory mole-
cules (i.e., CD40), stimulation of B cell division and sur-
vival, and Ig isotype switching. However, IL-4– or Stat-6–
deficient mice still do make antibodies, particularly of the
non-IgE isotypes (25–27). There is some evidence for a re-
lationship between T
 
FH
 
 and Th1 or Th2 cells. Th1 and
Th2 cells adoptively transferred to recipients can both mi-
grate to B cell follicles and support antibody production in
a CD154-dependent manner (28). Nevertheless Th1 and
Th2 cells do show differences in their localization in lym-
phoid tissue, with Th2 cells being much more follicle cen-
tric. In mice, this might relate to expression of CCR7,
which keeps Th1 cells closer to the T cell area, whereas its
absence allows Th2 cells to drift closer to the B cell follicles
(29). The most likely scenario is that T
 
FH
 
 cells are a separate
effector-type T cell that does not necessarily derive from
Th1 or Th2 cells. It could be that the T
 
FH
 
 subset expresses
cytokines and transcription factors particular only to these
cells. B cell activator belonging to the TNF family (BAFF),
a newly identified cytokine for B cell responses (30), is one
possibility.
There are important implications of a separate T
 
FH
 
 sub-
set, capable of facilitating B cell activation in a non-Th1/
Th2–related manner. One of these is that aspects of B cell
responses can occur independently of Th2 (and Th1) cy-
tokines. This would be consistent with the notion that Th2
responses are primarily designed for immunity against ex-
tracellular parasites. The Th1 and Th2 cytokines could be
seen as factors that skew the antibody response in one di-
rection or another depending on need for IgE for mast cell
activation, or the development of Ig isotypes that help in
the clearance of infected cells through opsonization and
phagocytosis. Like many aspects of immunology, there is
overlap and redundancy, because Th2 cells also show a de-
gree of follicular homing capability, high expression of
ICOS, and some helper function for antibody responses.
The relationship of T
 
FH
 
 to Th1 and Th2 cells, and the con-
ditions for interconversion among these three subsets, are
still missing pieces in the story. Irrespective of the many
unknown aspects of T
 
FH
 
 cells, these cells are an interesting
new extension to the Th1/Th2 paradigm.
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